New changes in US patent term adjustment calculations after Novartis v. Lee

References

• 1 Crouch D. USPTO Continues to Reduce Patent Term Adjustments. http://patentlyo.com.
  Google Scholar
• 2 See 35 U.S.C. § 154(b)(1)(A), (B), and (C).
  Google Scholar
• 3 See § 154(b)(2)(C).
  Google Scholar
• 4 Novartis AG v. Lee, 740 F.3d 593 (Fed. Cir. 2014).
  Google Scholar
• 5 80 Fed. Reg. 1346.
  Google Scholar
• 6 79 Fed. Reg. 34,681.
  Google Scholar
• 7 USPTO gov. www.uspto.gov/patents/law.
  Google Scholar
• 8 AIPLA letter of August 13, 2014, at 5; IPO letter of August 18, 2014, at 2; PhRMA letter of August 18, 2014, at 2. www.uspto.gov.
  Google Scholar
• 9 80 Fed. Reg. at 1346, 3rd column.
  Google Scholar
• 10 Id. at 1348, 1st column.
  Google Scholar
• 11 Id.
  Google Scholar
• 12 AIPLA letter at 2–3; IPO letter at 4–5; PhRMA letter at 4.
  Google Scholar
• 13 80 Fed. Reg. at 1348, 2nd column.
  Google Scholar
• 14 See AIPLA letter at 2–3; IPO letter at 4–5; PhRMA letter at 4.
  Google Scholar